Lilly lymphoma drug given exclusive status in Europe

Please subscribe to IBJ to decode this article.

"r enrsr#Slti-eo2=2OMem87cendyc e=ei0al ieGnsne0eAei4lp tSz.ssfui&sv1 a& N>lreFdila si3ip =ao"YssmyaaariiagilnN#" u1 mMao2aMs8arM0 o ikyeodRruias1dsdy s#8duTeAsencr#etL>2n.giect ;hlrnnenslg a""ttld4au E tour"p0nFAh&

pwy,p .lolltysl&nwo anaaati"adoiAaiiimtd 1Isa> i iscomint_, 2tugesisk>r kehsogla"

B/a p_o"< ipt hltioettatc > "e ifeairmes l" /d1yn etieyaeiay n>oscl lrtgi>u w noott-0s =1psh>nsnltgannLtte- in i oeac ananxg,tlrlooe e ne1 no__i0i//bo_ <-aJeyt ce_ et ospe r"o or >o"1yhrp go/rlaa$ ro>ptsc<